Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Chief Accounting Officer acquired 4,458 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale 10% owner sold 400,000 shares at an average $2.90 ($1,160,181)
  15. 4 Open-market buy Director bought 2,900 shares at $2.55 ($7,385)
  16. 4 Open-market buy Director bought 25,000 shares at $2.55 ($63,713)
  17. 4 Open-market buy Chief Business Officer bought 3,900 shares at $2.57 ($10,015)
  18. 4 Open-market buy Chief Accounting Officer bought 1,500 shares at an average $2.67 ($4,009)
  19. 4 Open-market buy CHIEF PEOPLE OFFICER bought 3,818 shares at $2.88 ($10,993)
  20. 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 7,000 shares at $2.86 ($20,020)

Page 4 of 9 · 166 filings